Creative Planning’s BioLife Solutions BLFS Stock Holding History

Creative Planning’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,925	Closed	-$206K	–	3497
2024 Q4	$206K	Buy	+7,925	New	+$197K	﹤0.01%	2955
2021 Q4	–	Sell	-5,000	Closed	-$212K	–	2098
2021 Q3	$212K	Hold	5,000	–	–	﹤0.01%	1826
2021 Q2	$223K	Sell	5,000 -1,300	-21%	-$45.8K	﹤0.01%	1744
2021 Q1	$227K	Buy	6,300 +100	+2%	+$3.95K	﹤0.01%	1993
2020 Q4	$247K	Buy	+6,200	New	+$211K	﹤0.01%	1747
2017 Q3	–	Sell	-143	Closed	–	–	2096
2017 Q2	$0	Hold	143	–	–	﹤0.01%	4621
2017 Q1	$0	Hold	143	–	–	﹤0.01%	4656
2016 Q4	$0	Hold	143	–	–	﹤0.01%	4620
2016 Q3	$0	Hold	143	–	–	﹤0.01%	4569
2016 Q2	$0	Hold	143	–	–	﹤0.01%	4355
2016 Q1	$0	Hold	143	–	–	﹤0.01%	4333
2015 Q4	$0	Hold	143	–	–	﹤0.01%	4410
2015 Q3	$0	Buy	+143	New	+$312	﹤0.01%	4293
2015 Q2	–	Sell	-143	Closed	–	–	1315
2015 Q1	$0	Hold	143	–	–	﹤0.01%	4214
2014 Q4	$0	Hold	143	–	–	﹤0.01%	4155
2014 Q3	$0	Hold	143	–	–	﹤0.01%	3992
2014 Q2	$0	Buy	+143	New	+$386	﹤0.01%	3780

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Creative Planning's BLFS Position: Q1 2025 in Review

Creative Planning sold out of BioLife Solutions (BLFS) in Q1 2025, closing a stake of 7,925 shares — an estimated $206K sold.

Creative Planning first reported a position in BLFS in Q2 2014 and held it in 17 quarters. The position peaked at $247K in Q4 2020. 188 funds tracked by Wall St. Rank hold BLFS as of Q1 2025.

Creative Planning reported no remaining BioLife Solutions position as of Q1 2025 after selling out during the quarter.
Creative Planning sold 7,925 BioLife Solutions shares in Q1 2025, an estimated $206K.
Creative Planning first reported a position in BioLife Solutions in Q2 2014 and held it in 17 quarters.
Creative Planning's BioLife Solutions position peaked at $247K in Q4 2020.
188 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2025.

Based on Creative Planning's 13F filing for Q1 2025, filed 15 May 2025.